In glioma cell lines such as U87MG and U251, low EphB3 levels are associated with increased proliferation, migration, and invasion, primarily through upregulation of EGFR and activation of the PI3K/AKT signaling pathway. The gene discussed is EPHB3; the disease is central nervous system cancer.